Date sent: Fri, 28 Dec 2001 Source: http://www.ahmf.org/01mcgregor.html Abstracts Sydney Conf. (24/35) = McGregor NR et al. --------------------------------------------- To retrospectively review the available data to develop a model of the disease processes occurring in CFS. McGregor NR [1], De Becker P [2], Clifton Bligh P [3], Stein E [1], Butt HL [1], De Meirleir K [2], Hoskin L [3], Dunstan RH [1], Fulcher G [3], King K [1], Niblett S [1], Roberts TK [1], Dunsmore J [3]. Collaborative Pain Research Unit: 1 Bioanalytical Research Group, Department of Biological Sciences, University of Newcastle, Callaghan, NSW 2308, and Neurobiology Research Unit University of Sydney, Westmead, Australia.; 2 Vrije Universiteit Brussel Vakgroep Interne Geneeskunde KRO gebouw niv. 1, Laarbeeklaan 101, 1090 Brussels Belgium.; 3 Royal North Shore CFS Unit Royal North Shore Hospital St Leonards NSW Australia. The medical literature and research finding from the three research groups involved in the presentation were assessed to develop the model. Results: Four factor analysis symptoms groupings are reported to occur in CFS patients: 1) general CFS symptoms, 2) cognitive symptoms, 3) musculoskeletal symptoms, and 4) mood change symptoms (De Becker et al, 2000). 1)The General CFS symptom group consists of the symptoms associated with reactivation of viruses, increased RNaseL fragmentation and infectious symptoms. This group of symptoms represent the cytokine inducing events or predominately pathogen associated events. 2-4)The cognitive, mood change and musculoskeletal symptoms represent the hosts response or cytokine-mediated symptoms. This is supported by the evidence of therapeutic use of cytokines in treatment of various diseases. In addition to the host based and viral associated symptom patterns are seen comorbid conditions such as bacterial induced disease and food intolerance that in turn induce changes in the host, which increase morbidity. A model of this complex set of interactions will be presented. The interaction of host and comorbid disease needs to be understood when CFS patients are assessed and treated. The infective/cytokine initiating symptoms appear associated with periods of reactivation of the syndrome. The subsequent cytokine mediated host based responses of cognitive, musculoskeletal and mood change symptoms are the bodies response to the syndrome initiators. Reactivation of different viruses is associated with symptom variation whilst the occurrence of comorbid infections and disease states increase patient morbidity.